Rainbow Childrens Medicare Limited — Important, 09-02-2025: Updates

The Board of Directors has approved the unaudited financial results for the quarter and nine months ended December 31, 2024. Key highlights include consolidated revenue from operations of ₹3,980.82 million for the quarter and ₹11,457.59 million for nine months, reflecting significant year-over-year growth. Profit after tax stands at ₹689.41 million for the quarter, with a year-to-date profit of ₹1,876.74 million, showcasing a stable trajectory.

Additionally, the company has appointed Ms. Shreya Mitra as Company Secretary and Compliance Officer, enhancing its governance structure. The Board has also approved the Employee Stock Option Scheme 2025, allowing for up to 10.15 lakh stock options to be granted to eligible employees. This initiative aims to boost employee motivation and align their interests with those of shareholders. The financial performance and strategic appointments contribute positively to the outlook, suggesting potential growth opportunities. Shareholders should watch these developments closely as they may shape the company's future performance.